BRAF and melanoma: To determine the role of CDK12 in melanoma, we performed RNA-sequencing (RNA-seq) on two BRAF-mutated melanoma cell lines (A375 and Colo829) treated with CDK12 inhibitors (THZ531; 500 nM) for 6 h (Supplementary Data 2).